Willow Leaves' Extracts Contain Anti-Tumor Agents Effective against Three Cell Types by El-Shemy, Hany A. et al.
Willow Leaves’ Extracts Contain Anti-Tumor Agents
Effective against Three Cell Types
Hany A. El-Shemy
1,3*, Ahmed M. Aboul-Enein
1, Khalid Mostafa Aboul-Enein
2, Kounosuke Fujita
3
1Department of Biochemistry, Faculty of Agriculture, Cairo University, Giza, Egypt, 2Department of Clinical Pathology, National Cancer Institute, Cairo
University, Cairo, Egypt, 3Graduate School of Biosphere Sciences, Hiroshima University, Hiroshima, Japan
Many higher plants contain novel metabolites with antimicrobial, antifungal and antiviral properties. However, in the
developed world almost all clinically used chemotherapeutics have been produced by in vitro chemical synthesis. Exceptions,
like taxol and vincristine, were structurally complex metabolites that were difficult to synthesize in vitro. Many non-natural,
synthetic drugs cause severe side effects that were not acceptable except as treatments of last resort for terminal diseases such
as cancer. The metabolites discovered in medicinal plants may avoid the side effect of synthetic drugs, because they must
accumulate within living cells. The aim here was to test an aqueous extract from the young developing leaves of willow (Salix
safsaf, Salicaceae) trees for activity against human carcinoma cells in vivo and in vitro. In vivo Ehrlich Ascites Carcinoma Cells
(EACC) were injected into the intraperitoneal cavity of mice. The willow extract was fed via stomach tube. The (EACC) derived
tumor growth was reduced by the willow extract and death was delayed (for 35 days). In vitro the willow extract could kill the
majority (75%–80%) of abnormal cells among primary cells harvested from seven patients with acute lymphoblastic leukemia
(ALL) and 13 with AML (acute myeloid leukemia). DNA fragmentation patterns within treated cells inferred targeted cell death
by apoptosis had occurred. The metabolites within the willow extract may act as tumor inhibitors that promote apoptosis,
cause DNA damage, and affect cell membranes and/or denature proteins.
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INTRODUCTION
Since human civilizations began, people have used plants for
medicine [1]. In fact, until this century, plant derived treatments,
faith, and surgery were the only treatments available. Among
developed countries people seeking alternative medicines to avoid
the side effects and expenses of synthetic medications have turned
back to herbs to treat a wide array of ailments [1].
Traditional medicine has a long history of serving peoples all
over the world [2]. Medicinal plants were an important element
of indigenous medical systems that has persisted in developing
countries. The enthnobotanic tradition and ubiquity of plants
provides a rich resource for natural drug research and develo-
pment. The plant kingdom was estimated to produce over 500,000
natural products and about 40–80 thousand per plant species [3].
Epidemiological and animal studies have demonstrated that plant-
derived dietary constituents of food play an important role in the
prevention of disease [4]. A number of food components have
been identified that inhibit the initiation and progression of cancer
or otherwise influence the potential for disease outcome [5]. For
example, some epidemiological studies showed a close association
between low incidence of coronary heart disease and breast cancer
[6] and moderate consumption of red wine containing natural
polyphenolic compounds [7].
Recently, the use of traditional medicine based on plants has
received considerable interest [8]. There are national and indigen-
ous rights over plant derived resources. Basic scientific investiga-
tions based on medicinal plants and indigenous medical systems
have increased. A screening program was initiated by Leven et al.
[9] that identified many antibacterial antifungal, antiviral, anti-
parasitic, and other pharmacologically active substance activities
in higher plants [10].
Fiehn et al. [11] used Mass Spectrometry to identify and
measure the abundance of hundreds of compounds in extracts
from several plant species including Arabidopsis thaliana, and potato
(Solanum tuberosa). More recently metabolite profiles that encompass
thousands of metabolites have been developed using FT-ICR-MS
in tobacco [12].
The genus Salix contained about 300 species. Salix has been
a used in many traditional treatments [13] but is famous as the
source of salicylic acid (Aspirin) that is stored in abundance just
under the tree bark [14]. Aspirin is now synthesized in vitro and is
free of impurities and co-metabolites. It has been used to reduce
blood pressure, to thin blood by reducing the platelet count and to
treat headaches. About 32 novel compounds have been identified
in Salix sp. though no exhaustive metabolite profiles were availa-
ble in 2006. In previous studies the active principles of the willow
leaf extracts (Salicin and Saliginin chemicals related to salicylic
acid) were shown to be anti-leukemia agents [13]. This work
investigated the effect of Salicin and Saliginin in willow leaf
extracts on the viability of tumor cells.
MATERIALS AND METHODS
Samples Preparation
The willow leaves (Salix safsaf L.) were collected from the Salix
farm of the Faculty of Agriculture, Cairo University, Giza, Egypt.
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extracted in hot water (at 10% w/v). About 10 g of fresh leaves
were boiled (at 100uC) in 100 ml distilled water for 20 min, then
filtered through a sterilized Miracloth and centrifuged at 15,000 g
for 15 min. The Salicin concentration was about 750 ng/ml. The
organic solvent extraction was carried out with the plant leaves as
follows; 80 g leaves were extracted consecutively at room
temperature with petroleum ether (at 40–60uC), that was followed
by diethyl ether, chloroform, acetone, and finally with 70% (v/v)
ethanol. The solvent of each extract was removed by distillation at
a low temperature.
The study was performed on cells harvested from adult
leukemia patients or healthy relatives, aged 18–65 years that were
admitted to the National Cancer Institute, Cairo University.
International protocols governing the ethical treatment of patient
were followed. In addition animals were transplanted with EACC
from an immortal culture obtained from National Cancer
Institute, Cairo University, and maintained at mice transplanted
line. International protocols governing the ethical treatment of
animals were followed.
Viability of Tumor Cells
The experimental samples were taken from healthy volunteers (6
samples) and leukemia patients that included 7 ALL (acute
lymphoblastic leukemia) and 13 AML (acute myeloid leukemia,
immature monocytes) patients. ALL and AML had been di-
agnosed by peripheral blood and bone marrow examination,
cytochemistry (and immunological markers in some cases).
Mononuclear cells were separated from other blood cells by Ficoll
hypaque density gradient (Pharmacia, Uppsala, Sweden). The cells
were then washed with three changes of PBS. The cell counts were
adjusted to 10
5 cells/0.1 ml (counting both mature and immature
cells). The culture medium was prepared using modified Earle’s
salt with 1.2 g/l sodium carbonate and L-glutamine (Gibco,
Grand island, USA), 10% inactivated fetal bovine serum (Gibco),
and 100 units ml
21 penicillin and 100 mgm l
21 streptomycin.was
added. The medium was filtered through 0.22 mm Millipore filter,
one ml of which was transferred into a 1.8-ml screw-capped sterile
plastic tube. Next, 0.1 ml of the cell suspension containing 10
5
cells was added to each of 5 tubes. To three of the tubes, 0.1 ml of
the willow extract was added, while the other two tubes served as
negative and positive controls. Culture medium was used instead
of the willow extract for the negative control and the willow extract
was added to the cells from healthy volunteers as a positive control.
The tubes were incubated at 37uC in the presence of 5% (v/v)
CO2 for 24 h (dark condition, humidified air). The cells were
tested for their viability using the trypan blue exclusion test [15].
Two hundred cells were counted, and the percentage of viable
cells was estimated.
Cells of EACC were obtained from transplanted animals and
then washed with three changes of PBS. The cell counts were
adjusted to 10
5 cells/0.1 ml. The purification methods and
treatment protocols described above were used to determine the
effects of willow extracts on the viability of EACC.
Tumor Transplanted Animals
A total of 36 normal female Swiss albino mice weighing between
20–25 g each and fed a normal diet were used as follows: One
group of mice were spared a cell transplant and referred to as the
control (negative). The second group was transplanted to the
intraperitoneal (i.p) cavity with EACC at 2610
6 cells (0.2 ml)
(positive control). The third group was transplanted with EACC
like the second group and each mouse was daily forced to ingest
orally via stomach tube about 0.2 ml of an aqueous willow extract
(10% w/v) in addition to the normal diet. The fourth group were
treated daily like the third group except with 0.6 ml willow extract.
DNA Extraction
DNA was extracted from mature (normal cells) and immature
white blood cells (leukemic cells) before and after treatment with
willow extract. Cells were washed with PBS and then lysed in cold
lysis solution (5 mmol/L of Tris, pH 7.4, 20 mmol/L of EDTA,
0.5% Triton X-100) for 20 min [16]. Cell lysates were centrifuged
at 27,000 g for 15 min, and DNA was extracted from the aqueous
phase with phenol:chloroform:isoamyl alcohol (25:24:1,v/v/v)
containing 0.1% (w/v) hydroxyquinoline. DNA was precipitated
with 0.3 mol/L of sodium acetate and 2 volumes of cold 100% (v/
v) ethanol. Agarose gel electrophoresis (1% w/v) at 30 mA for 2 h
followed by UV fluorescence was used to determine the degree of
apoptotic DNA fragmentation [16].
RESULTS AND DISCUSSION
After 24 h incubation of the mononuclear ALL cells with salix
extract, a remarkable destruction of lymphoblasts (75%) occurred
that was significantly higher than the control (7%; Figure 1). In the
case of mononuclear AML cells similar trends were observed, the
mean viability of willow extract treated cells was 26.2% when
compared to the control (96.9%; Figure 2). The willow extract was
incubated with normal mononuclear cells as a positive control
from healthy volunteers (6 samples). The results showed that there
was no significant difference in killing the cells (mean 7.8% and
6.7%) when compared to 3.1% in the control (negative control).
From these data, it is clear that leukemia cells were more
vulnerable to the extract.
The anti-tumor effects of willow leaf extracts were novel.
However, willow leaves have long been used in folk medicine as an
antirheumatic, analgesic, and antipyretic herbal medicine. In
connection with antileukemia, the allamandin derivatives that are
extracted with water and/or ethanol from Allamanda catharica
Figure 1. The effect of willow young leaves extracts on the viability of
ALL cells. 7 ALL patients (acute lymphoblastic leukemia) 0.1 ml of the
cell suspension containing 10
5 cells was added to 5 tubes. To three of
the tubes, 0.1 ml of the willow extract was added, while the other two
tubes served as negative and positive controls. Culture medium was
used instead of the willow extract for the negative control and the
willow extract was added to the cells from healthy volunteers as
a positive control. The tubes were incubated for 24 h and tested for
their viability using the trypan blue.
doi:10.1371/journal.pone.0000178.g001
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leukemia in the mouse [17].
Various fractions including different leaf extracts (Salix safsaf)b y
successive solvent extractions were tested for their antileukemic
activity on acute myeloid leukemia (AML) cells and acute lympho-
blastic leukemia (ALL). The fractions of each crude extract were
dissolved in a saline solution after removing the solvent and incu-
bated with the leukemia cells. The results showed that a fraction of
the willow leaves extracted with nonpolar organic solvents
(petroleum ether, ether, and chloroform) had a very low destruc-
tive effect on tumor cells as shown by a higher viability 80–90%.
Destruction of each extract ranged between 1.5–2.9%. of each
extract. However, a major destructive effect on AML, ALL and
carcinoma (EACC) cells was obtained by a fraction of the polar
organic solvents (water and 70% ethanol).
The viability of tumor cells (EACC) after incubation with water
extract of salix leaves were greatly affected (80% cell death)
compared to untreated cells (2% cell death) (Figure 3). From this
observation, it is clear that the antitumor activity of the willow
leaves was mostly due to compounds that were soluble in water
and/or ethanol. These active ingredients were easily dissolved in
hot water, and in turn could be used as a natural antitumor
medicine. The phenolic compounds, most glycosides, and many
types of tannin will dissolve in water or ethanol solutions [18].
Therefore, these groups of compounds may contain the major
active components for the destruction of leukemia and carcinoma
cells. Salicin was the primary compound in salix leaves that could
be dissolved in water and ethanol. Salicin was identified by
comparing the retention time and spectral characteristics of the
extract to those of the reference compounds by GCMS and
HPLC. Here, the salicin standard (Sigma, St. Louis, USA) was
tested for its antileukemic and anti-carcinoma cells effect. Salicin
(0.1 ml of a 0.75 mg/ml) was added to the suspension of 10
5
AML, ALL and EACC cells. The results showed that the destruc-
tion of myeloblasts and tumor cells (70–75%) was significantly
higher than those in the control specimens. From these
observations, salicin may be the major component that shows
the anti-tumor effect but other metabolite may increase the
potency of the willow extract compared to pure salicin.
Transport of salicin and saligenin into erythrocytes was rapid
for saligenin (1 min to saturation) compared with salicin (4 h to
saturation)[19]. The process was reversible, exhibiting a rapid
release for saligenin and slower release for salicin [19]. Both
saligenin and salicin bind to human serum albumin, but the
former has the significantly higher affinity [19]. Ehrlich asites
tumor (EACC) in mice had been used as a model for rapidly
growing tumors where various experimental anticancer agents can
be applied. Herein analyses of transplanted animals before and
Figure 2. The effect of willow young leaves extracts on the viability of
AML cells. 13 AML patients (acute myeloid leukemia) 0.1 ml of the cell
suspension containing 10
5 cells was added to 5 tubes. To three of the
tubes, 0.1 ml of the willow extract was added, while the other two
tubes served as negative and positive controls. Culture medium was
used instead of the willow extract for the negative control and the
willow extract was added to the cells from healthy volunteers as
a positive control. The tubes were incubated at tested for their viability
using the trypan blue.
doi:10.1371/journal.pone.0000178.g002
Figure 3. The effect of willow young leaves extracts on the viability of
Ehrlich asites carcinoma cells (EACC). 0.1 ml of the cell suspension
containing 10
5 cells was added to 4 tubes. To three of the tubes, 0.1 ml
of the willow extract was added, while the other tube served as
negative control. Culture medium was used instead of the willow
extract for the negative control. The tubes were incubated for 24 h and
tested for their viability using the trypan blue.
doi:10.1371/journal.pone.0000178.g003
Figure 4. Effect of salix water extract on surviving of transplanted
animals (EACC). One group fed on normal diet (negative control),
second group was fed on normal diet and transplanted to the
intraperitoneal (i.p) cavity with EACC at 2610
6 cells (0.2 ml) (positive
control), third group fed the normal diet and EACC infected then each
mouse daily forced to ingest orally via stomach tube about 0.2 ml of an
aqueous willow extract (10% w/v), fourth group were treated daily like
the third group except with 0.6 ml willow extract.
doi:10.1371/journal.pone.0000178.g004
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administration. The results showed that water extract of willow
leaves delayed the death and inhibited the tumor growth of
transplanted animals compared with untreated transplanted
animals that died within two weeks (Figure 4). However, the
active principles in water extracts modified the features of EACC
hampering their growth after transplantation.
Side effect tests on animals showed salix extract did not induce
widespread cell damage. There was no difference between the
feeding and non-feeding animals in blood glucose, GOT, GPT
and alkaline phosphatase activity. Salicin was partially metabo-
lized to saligenin and salicylic acid (a known effective compound)
after incubation with homogenized kidneys from rats [20].
Saligenin was transformed to salicylic acid by homogenized liver,
lung, and kidney extracts. Gentisic acid was qualitatively detect-
able in the homogenized liver after incubation with saligenin [20].
The transport of salicin and saligenin through the isolated
intestinal wall was confirmed using the closed-off posterior section
of the male rat intestine. When salicin and saligenin were injected
into the closed intestine, both passed unchanged through the ileal
wall. Saligenin appeared to penetrate the intestinal wall faster than
salicin [21]. The metabolites were equivalent to more than 86% of
the administered salicin, that were recovered in 24-h urine:
salicyluric acid (51%), salicyl glucuronide (14%), salicylic acid
(12%), gentisic acid (5%), and saligenin (49%) together with a small
amount of unchanged salicin [22]. Based on these findings, it is
speculated that the tumor cells may emit some signaling substances
for salicin and saligenin receptors. The willow compounds may
bind with receptors on the surface of tumor cells and penetrate
into the cells. The cells could be killed through denaturation of
some enzymes and proteins that are induced by salicin and
saligenin (Figure. 5). Signaling between cells is commonly regarded
as the most important mechanism by which cell-type differences
arise in development and by which patterns of tissue organization
are established [23]. At almost every stage in development, cells
emit and receive signals from other nearby cells, and these signals
are necessary for normal differentiation and function [23].
Little is known about the bioavailability, absorption and meta-
bolism of secondary metabolites of salix tree in humans and it is
likely that different groups of compounds have different pharma-
cokinetic properties. The study reported here describes a simple
mode of action of salicin and saligenin compounds to bind with the
immature white blood cells only and destroy them with apoptosis
associated DNA damage (Figure 5). Highly DNA damaged in
leukemic cells incubated with salix extract was surprising when
normal cells incubated with salix extract remained unaffected
(Figure 5).
Even assuming unknown receptors in the surface of leukemic
cells may be binding with salix extract compounds and leading to
DNA destruction (Figure 5) the mode of action of salicin and
Figure 5. The mode of action of the Salicin and Saligenin to destroy immature White Blood Cells (WBC’s) in leukemia patients.
doi:10.1371/journal.pone.0000178.g005
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Figure 5, will need more clinical experiments to elucidate the
receptors and transduction pathways induced in leukemic cells.
Gao and his coworker [16] have investigated the resveratrol-
induced DNA fragmentation in 32Dp210 leukemic cells. Resver-
atrol induced apoptosis in 32Dp210 cells as supported by the
induction of internucleosomal DNA fragmentation and the
cleavage of procaspase-3 in resveratrol treated cells [16]. These
results supported the previously reported apoptosis-inducing
activity of resveratrol against tumor cell lines [24.25].
In conclusion the message from Arabian and Middle East
researchers to medical scientists over the world was to get back in
nature and search for new drugs, to avoid the side effect of
chemical therapy and to help patients recover from acute diseases.
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